Epilepsy Talk
Dilantin – Hero or Horror?
May 1, 2022
28 Comments
28 Comments
Since it first came out, Dilantin has always had its fans and its detractors.
Who can forget Jack Nicholson’s out-of-control behavior as the “crazy” in Ken Kesey’s “One Flew Over the Cuckoo’s Nest”!
Posted in Epilepsy
Tags: Birth Defects, bone weakening, Brain Atrophy, dangers, Dilantin, FDA, Gingivitis, Neuropathy, Purple Glove Syndrome, risks, seizures, side effects, Stevens-Johnson Syndrome
Tags: Birth Defects, bone weakening, Brain Atrophy, dangers, Dilantin, FDA, Gingivitis, Neuropathy, Purple Glove Syndrome, risks, seizures, side effects, Stevens-Johnson Syndrome
Increased Birth Defect Risks in Two FDA-Approved Epilepsy Medications
October 20, 2011
2 Comments
2 Comments
Two epilepsy drugs – Lamictal and Keppra – which are currently listed in category C may be dangerous to a fetus and should be listed in category D, according to new data. The difference between the categories is that D shows evidence of risk, but the benefits outweigh the risks…
Posted in Epilepsy, Medication Issues, News, Research
Tags: Birth Defects, dangers, Epilepsy, Keppra, Lamictal, pregnancy
Tags: Birth Defects, dangers, Epilepsy, Keppra, Lamictal, pregnancy
About the author
Epilepsy Talk 